Compile Data Set for Download or QSAR

Found 260 hits with Last Name = 'brimert' and Initial = 't'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Galectin-3 (Homo sapiens (Human))	BDBM461847 (3,4-Dichlorophenyl 3-deoxy-3-[4-(2,3,4,5,6-pentafl...) Show SMILES OCC1O[C@@H](C(O)[C@H]([C@H]1O)n1cc(nn1)-c1c(F)c(F)c(F)c(F)c1F)S(=O)c1ccc(Cl)c(Cl)c1 |r| Show InChI InChI=1S/C20H14Cl2F5N3O5S/c21-7-2-1-6(3-8(7)22)36(34)20-19(33)17(18(32)10(5-31)35-20)30-4-9(28-29-30)11-12(23)14(25)16(27)15(26)13(11)24/h1-4,10,17-20,31-33H,5H2/t10?,17-,18-,19?,20+,36?/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461848 (5-Chloropyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluoro...) Show SMILES OCC1O[C@H](Sc2cncc(Cl)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C19H16ClF3N4O4S/c20-9-3-10(5-24-4-9)32-19-18(30)16(17(29)14(7-28)31-19)27-6-13(25-26-27)8-1-11(21)15(23)12(22)2-8/h1-6,14,16-19,28-30H,7H2/t14?,16-,17-,18?,19+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	35	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461849 (5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...) Show SMILES OCC1O[C@H](Sc2cncc(Br)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C19H16BrF3N4O4S/c20-9-3-10(5-24-4-9)32-19-18(30)16(17(29)14(7-28)31-19)27-6-13(25-26-27)8-1-11(21)15(23)12(22)2-8/h1-6,14,16-19,28-30H,7H2/t14?,16-,17-,18?,19+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	23	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461850 (3-Chloro-5-cyanophenyl 3-deoxy-3-[4-(3,4,5-trifluo...) Show SMILES OCC1O[C@H](Sc2cc(Cl)cc(c2)C#N)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C21H16ClF3N4O4S/c22-11-1-9(6-26)2-12(5-11)34-21-20(32)18(19(31)16(8-30)33-21)29-7-15(27-28-29)10-3-13(23)17(25)14(24)4-10/h1-5,7,16,18-21,30-32H,8H2/t16?,18-,19-,20?,21+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	41	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461851 (3-Chloro-4-cyanophenyl 3-deoxy-3-[4-(3,4,5-trifluo...) Show SMILES OCC1O[C@H](Sc2ccc(C#N)c(Cl)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C21H16ClF3N4O4S/c22-12-5-11(2-1-9(12)6-26)34-21-20(32)18(19(31)16(8-30)33-21)29-7-15(27-28-29)10-3-13(23)17(25)14(24)4-10/h1-5,7,16,18-21,30-32H,8H2/t16?,18-,19-,20?,21+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	31	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461852 (3-Chloro-6-fluoro-4-cyanophenyl 3-deoxy-3-[4-(3,4,...) Show SMILES OCC1O[C@H](Sc2cc(Cl)c(cc2F)C#N)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C21H15ClF4N4O4S/c22-10-4-16(11(23)3-9(10)5-27)35-21-20(33)18(19(32)15(7-31)34-21)30-6-14(28-29-30)8-1-12(24)17(26)13(25)2-8/h1-4,6,15,18-21,31-33H,7H2/t15?,18-,19-,20?,21+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	29	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461853 (3-Bromo-4-cyanophenyl 3-deoxy-3-[4-(3,4,5-trifluor...) Show SMILES OCC1O[C@H](Sc2ccc(C#N)c(Br)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C21H16BrF3N4O4S/c22-12-5-11(2-1-9(12)6-26)34-21-20(32)18(19(31)16(8-30)33-21)29-7-15(27-28-29)10-3-13(23)17(25)14(24)4-10/h1-5,7,16,18-21,30-32H,8H2/t16?,18-,19-,20?,21+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	43	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461854 (5-Bromo-6-trifluoromethyl-pyridin-3-yl 3-deoxy-3-[...) Show SMILES OCC1O[C@H](Sc2cnc(c(Br)c2)C(F)(F)F)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C20H15BrF6N4O4S/c21-9-3-8(4-28-18(9)20(25,26)27)36-19-17(34)15(16(33)13(6-32)35-19)31-5-12(29-30-31)7-1-10(22)14(24)11(23)2-7/h1-5,13,15-17,19,32-34H,6H2/t13?,15-,16-,17?,19+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	23	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461855 (5-Chloro-6-cyano-pyridin-3-yl 3-deoxy-3-[4-(3,4,5-...) Show SMILES OCC1O[C@H](Sc2cnc(C#N)c(Cl)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C20H15ClF3N5O4S/c21-10-3-9(5-26-13(10)4-25)34-20-19(32)17(18(31)15(7-30)33-20)29-6-14(27-28-29)8-1-11(22)16(24)12(23)2-8/h1-3,5-6,15,17-20,30-32H,7H2/t15?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	39	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461856 (5-Chloro-6-cyano-pyridazin-3-yl 3-deoxy-3-[4-(3,4,...) Show SMILES OCC1O[C@H](Sc2cc(Cl)c(nn2)C#N)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C19H14ClF3N6O4S/c20-8-3-14(27-25-11(8)4-24)34-19-18(32)16(17(31)13(6-30)33-19)29-5-12(26-28-29)7-1-9(21)15(23)10(22)2-7/h1-3,5,13,16-19,30-32H,6H2/t13?,16-,17-,18?,19+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	54	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461857 (3,4-Dichlorophenyl 3-deoxy-1-thio-3-[4-(2,3,4,5,6-...) Show SMILES OCC1O[C@H](Sc2ccc(Cl)c(Cl)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1c(F)c(F)c(F)c(F)c1F |r| Show InChI InChI=1S/C20H14Cl2F5N3O4S/c21-7-2-1-6(3-8(7)22)35-20-19(33)17(18(32)10(5-31)34-20)30-4-9(28-29-30)11-12(23)14(25)16(27)15(26)13(11)24/h1-4,10,17-20,31-33H,5H2/t10?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	37	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461858 (3,4-Dichlorophenyl 3-deoxy-3-[4-(2,3,4,5,6-pentafl...) Show SMILES OCC1O[C@@H](C(O)[C@H]([C@H]1O)n1cc(nn1)-c1c(F)c(F)c(F)c(F)c1F)S(=O)(=O)c1ccc(Cl)c(Cl)c1 |r| Show InChI InChI=1S/C20H14Cl2F5N3O6S/c21-7-2-1-6(3-8(7)22)37(34,35)20-19(33)17(18(32)10(5-31)36-20)30-4-9(28-29-30)11-12(23)14(25)16(27)15(26)13(11)24/h1-4,10,17-20,31-33H,5H2/t10?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	13	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461859 (5-Methoxy-6-cyano-pyridazin-3-yl 3-deoxy-3-[4-(3,4...) Show SMILES COc1cc(S[C@H]2OC(CO)[C@H](O)[C@@H](C2O)n2cc(nn2)-c2cc(F)c(F)c(F)c2)nnc1C#N |r| Show InChI InChI=1S/C20H17F3N6O5S/c1-33-13-4-15(27-25-11(13)5-24)35-20-19(32)17(18(31)14(7-30)34-20)29-6-12(26-28-29)8-2-9(21)16(23)10(22)3-8/h2-4,6,14,17-20,30-32H,7H2,1H3/t14?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	250	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461860 (5-Hydroxy-6-cyano-pyridazin-3-yl 3-deoxy-3-[4-(3,4...) Show SMILES OCC1O[C@H](Sc2cc(O)c(nn2)C#N)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C19H15F3N6O5S/c20-8-1-7(2-9(21)15(8)22)11-5-28(27-25-11)16-17(31)13(6-29)33-19(18(16)32)34-14-3-12(30)10(4-23)24-26-14/h1-3,5,13,16-19,29,31-32H,6H2,(H,26,30)/t13?,16-,17-,18?,19+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	940	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461861 (3-Chloro-2,4-difluorophenyl 3-deoxy-1-thio-3-[4-(3...) Show SMILES OCC1O[C@H](Sc2ccc(F)c(Cl)c2F)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C20H15ClF5N3O4S/c21-14-8(22)1-2-13(16(14)26)34-20-19(32)17(18(31)12(6-30)33-20)29-5-11(27-28-29)7-3-9(23)15(25)10(24)4-7/h1-5,12,17-20,30-32H,6H2/t12?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	150	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461862 (3,4-Dichlorophenyl 3-deoxy-3-[4-(phenyl)-1H-1,2,3-...) Show SMILES OCC1O[C@H](Sc2ccc(Cl)c(Cl)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1ccccc1 |r| Show InChI InChI=1S/C20H19Cl2N3O4S/c21-13-7-6-12(8-14(13)22)30-20-19(28)17(18(27)16(10-26)29-20)25-9-15(23-24-25)11-4-2-1-3-5-11/h1-9,16-20,26-28H,10H2/t16?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	1.45E+3	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461863 (3,5-Dichloro-4-fluorophenyl 3-deoxy-3-[4-(3,4,5-tr...) Show SMILES OCC1O[C@H](Sc2cc(Cl)c(F)c(Cl)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C20H15Cl2F4N3O4S/c21-9-3-8(4-10(22)15(9)25)34-20-19(32)17(18(31)14(6-30)33-20)29-5-13(27-28-29)7-1-11(23)16(26)12(24)2-7/h1-5,14,17-20,30-32H,6H2/t14?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	18	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461864 (3,4-Dichloro-6-fluorophenyl 3-deoxy-3-[4-(3,4,5-tr...) Show SMILES OCC1O[C@H](Sc2cc(Cl)c(Cl)cc2F)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C20H15Cl2F4N3O4S/c21-8-3-10(23)15(4-9(8)22)34-20-19(32)17(18(31)14(6-30)33-20)29-5-13(27-28-29)7-1-11(24)16(26)12(25)2-7/h1-5,14,17-20,30-32H,6H2/t14?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	27	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461865 (3-Bromo-4-fluorophenyl 3-deoxy-3-[4-(3,4,5-trifluo...) Show SMILES OCC1O[C@H](Sc2ccc(F)c(Br)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C20H16BrF4N3O4S/c21-10-5-9(1-2-11(10)22)33-20-19(31)17(18(30)15(7-29)32-20)28-6-14(26-27-28)8-3-12(23)16(25)13(24)4-8/h1-6,15,17-20,29-31H,7H2/t15?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	24	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461866 (3-Chloro-4-(trifluoromethyl)phenyl 3-deoxy-1-thio-...) Show SMILES OCC1O[C@H](Sc2ccc(c(Cl)c2)C(F)(F)F)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C21H16ClF6N3O4S/c22-11-5-9(1-2-10(11)21(26,27)28)36-20-19(34)17(18(33)15(7-32)35-20)31-6-14(29-30-31)8-3-12(23)16(25)13(24)4-8/h1-6,15,17-20,32-34H,7H2/t15?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	31	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461867 (3,4,5-Trichlorophenyl 3-deoxy-1-thio-3-[4-(3,4,5-t...) Show SMILES OCC1O[C@H](Sc2cc(Cl)c(Cl)c(Cl)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C20H15Cl3F3N3O4S/c21-9-3-8(4-10(22)15(9)23)34-20-19(32)17(18(31)14(6-30)33-20)29-5-13(27-28-29)7-1-11(24)16(26)12(25)2-7/h1-5,14,17-20,30-32H,6H2/t14?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	34	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461868 (5-Chloro-2-fluorophenyl 3-deoxy-1-thio-3-[4-(3,4,5...) Show SMILES OCC1O[C@H](Sc2cc(Cl)ccc2F)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C20H16ClF4N3O4S/c21-9-1-2-10(22)15(5-9)33-20-19(31)17(18(30)14(7-29)32-20)28-6-13(26-27-28)8-3-11(23)16(25)12(24)4-8/h1-6,14,17-20,29-31H,7H2/t14?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	46	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461869 (5-Bromo-2-fluorophenyl 3-deoxy-1-thio-3-[4-(3,4,5-...) Show SMILES OCC1O[C@H](Sc2cc(Br)ccc2F)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C20H16BrF4N3O4S/c21-9-1-2-10(22)15(5-9)33-20-19(31)17(18(30)14(7-29)32-20)28-6-13(26-27-28)8-3-11(23)16(25)12(24)4-8/h1-6,14,17-20,29-31H,7H2/t14?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	47	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461870 (5-Chloro-2-methoxyphenyl 3-deoxy-1-thio-3-[4-(3,4,...) Show SMILES OCC1O[C@H](Sc2cc(Cl)ccc2CO)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C21H19ClF3N3O5S/c22-11-2-1-9(7-29)16(5-11)34-21-20(32)18(19(31)15(8-30)33-21)28-6-14(26-27-28)10-3-12(23)17(25)13(24)4-10/h1-6,15,18-21,29-32H,7-8H2/t15?,18-,19-,20?,21+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	84	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461871 (3-Iodophenyl 3-deoxy-1-thio-3-[4-(3,4,5-trifluorop...) Show SMILES OCC1O[C@H](Sc2cccc(I)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C20H17F3IN3O4S/c21-12-4-9(5-13(22)16(12)23)14-7-27(26-25-14)17-18(29)15(8-28)31-20(19(17)30)32-11-3-1-2-10(24)6-11/h1-7,15,17-20,28-30H,8H2/t15?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	90	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461872 (Picolinamide-5-yl 3-deoxy-3-[4-(3,4,5-trifluorophe...) Show SMILES NC(=O)c1ccc(S[C@H]2OC(CO)[C@H](O)[C@@H](C2O)n2cc(nn2)-c2cc(F)c(F)c(F)c2)cn1 |r| Show InChI InChI=1S/C20H18F3N5O5S/c21-10-3-8(4-11(22)15(10)23)13-6-28(27-26-13)16-17(30)14(7-29)33-20(18(16)31)34-9-1-2-12(19(24)32)25-5-9/h1-6,14,16-18,20,29-31H,7H2,(H2,24,32)/t14?,16-,17-,18?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	180	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461873 (3-Cyanophenyl 3-deoxy-1-thio-3-[4-(3,4,5-trifluoro...) Show SMILES OCC1O[C@H](Sc2cccc(c2)C#N)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C21H17F3N4O4S/c22-13-5-11(6-14(23)17(13)24)15-8-28(27-26-15)18-19(30)16(9-29)32-21(20(18)31)33-12-3-1-2-10(4-12)7-25/h1-6,8,16,18-21,29-31H,9H2/t16?,18-,19-,20?,21+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	192	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461874 (2-cyanopyridine-5-yl 3-deoxy-3-[4-(3,4,5-trifluoro...) Show SMILES OCC1O[C@H](Sc2ccc(nc2)C#N)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C20H16F3N5O4S/c21-12-3-9(4-13(22)16(12)23)14-7-28(27-26-14)17-18(30)15(8-29)32-20(19(17)31)33-11-2-1-10(5-24)25-6-11/h1-4,6-7,15,17-20,29-31H,8H2/t15?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	260	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461875 (4-Chloro-2-thienyl 3-deoxy-3-[4-(3,4,5-trifluoroph...) Show SMILES OCC1O[C@H](Sc2cc(Cl)cs2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C18H15ClF3N3O4S2/c19-8-3-13(30-6-8)31-18-17(28)15(16(27)12(5-26)29-18)25-4-11(23-24-25)7-1-9(20)14(22)10(21)2-7/h1-4,6,12,15-18,26-28H,5H2/t12?,15-,16-,17?,18+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	330	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461876 (3-Carboxyphenyl 3-deoxy-3-[4-(3,4,5-trifluoropheny...) Show SMILES OCC1O[C@H](Sc2cccc(c2)C(O)=O)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C21H18F3N3O6S/c22-12-5-10(6-13(23)16(12)24)14-7-27(26-25-14)17-18(29)15(8-28)33-21(19(17)30)34-11-3-1-2-9(4-11)20(31)32/h1-7,15,17-19,21,28-30H,8H2,(H,31,32)/t15?,17-,18-,19?,21+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	350	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461877 (Benzamide-3-yl 3-deoxy-3-[4-(3,4,5-trifluorophenyl...) Show SMILES NC(=O)c1cccc(S[C@H]2OC(CO)[C@H](O)[C@@H](C2O)n2cc(nn2)-c2cc(F)c(F)c(F)c2)c1 |r| Show InChI InChI=1S/C21H19F3N4O5S/c22-12-5-10(6-13(23)16(12)24)14-7-28(27-26-14)17-18(30)15(8-29)33-21(19(17)31)34-11-3-1-2-9(4-11)20(25)32/h1-7,15,17-19,21,29-31H,8H2,(H2,25,32)/t15?,17-,18-,19?,21+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	380	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461878 (3,4-Dichlorophenyl 3-deoxy-3-[4-(3,4-difluoropheny...) Show SMILES OCC1O[C@H](Sc2ccc(Cl)c(Cl)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1ccc(F)c(F)c1 |r| Show InChI InChI=1S/C20H17Cl2F2N3O4S/c21-11-3-2-10(6-12(11)22)32-20-19(30)17(18(29)16(8-28)31-20)27-7-15(25-26-27)9-1-4-13(23)14(24)5-9/h1-7,16-20,28-30H,8H2/t16?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	110	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461879 (3,4-Dichlorophenyl 3-deoxy-3-[4-(3,4-difluoropheny...) Show SMILES OCC1O[C@H](Sc2ccc(Cl)c(Cl)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C20H17Cl2F2N3O4S/c21-13-2-1-12(6-14(13)22)32-20-19(30)17(18(29)16(8-28)31-20)27-7-15(25-26-27)9-3-10(23)5-11(24)4-9/h1-7,16-20,28-30H,8H2/t16?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	110	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461880 (3,4-Dichlorophenyl 3-deoxy-3-[4-(3-fluorophenyl)-1...) Show SMILES OCC1O[C@H](Sc2ccc(Cl)c(Cl)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cccc(F)c1 |r| Show InChI InChI=1S/C20H18Cl2FN3O4S/c21-13-5-4-12(7-14(13)22)31-20-19(29)17(18(28)16(9-27)30-20)26-8-15(24-25-26)10-2-1-3-11(23)6-10/h1-8,16-20,27-29H,9H2/t16?,17-,18-,19?,20+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	140	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461881 (3,3′-difluoro-cyklohexyl 3-deoxy-3-[4-(3,4,5...) Show SMILES OCC1O[C@H](SC2CCCC(F)(F)C2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C20H22F5N3O4S/c21-11-4-9(5-12(22)15(11)23)13-7-28(27-26-13)16-17(30)14(8-29)32-19(18(16)31)33-10-2-1-3-20(24,25)6-10/h4-5,7,10,14,16-19,29-31H,1-3,6,8H2/t10?,14?,16-,17-,18?,19+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	240	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461882 (US10774102, Example 77 | n-Butyl 3-deoxy-3-[4-(3,4...) Show SMILES CCCCS[C@H]1OC(CO)[C@H](O)[C@@H](C1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C18H22F3N3O4S/c1-2-3-4-29-18-17(27)15(16(26)13(8-25)28-18)24-7-12(22-23-24)9-5-10(19)14(21)11(20)6-9/h5-7,13,15-18,25-27H,2-4,8H2,1H3/t13?,15-,16-,17?,18+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	450	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461883 (3,4-Dichlorophenyl 3-deoxy-3-[4-(3,5-difluoro-4-me...) Show SMILES COc1c(F)cc(cc1F)-c1cn(nn1)[C@H]1[C@@H](O)C(CO)O[C@H](Sc2ccc(Cl)c(Cl)c2)C1O |r| Show InChI InChI=1S/C21H19Cl2F2N3O5S/c1-32-20-13(24)4-9(5-14(20)25)15-7-28(27-26-15)17-18(30)16(8-29)33-21(19(17)31)34-10-2-3-11(22)12(23)6-10/h2-7,16-19,21,29-31H,8H2,1H3/t16?,17-,18-,19?,21+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	470	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461884 (2-hydroxy-pyridin-4-yl 3-deoxy-3-[4-(3,4,5-trifluo...) Show SMILES OCC1O[C@H](Sc2cc[nH]c(=O)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	510	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461885 (2-Chlorophenethyl 3-deoxy-3-[4-(3,4,5-trifluorophe...) Show SMILES OCC1O[C@H](SCCc2ccccc2Cl)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C22H21ClF3N3O4S/c23-13-4-2-1-3-11(13)5-6-34-22-21(32)19(20(31)17(10-30)33-22)29-9-16(27-28-29)12-7-14(24)18(26)15(25)8-12/h1-4,7-9,17,19-22,30-32H,5-6,10H2/t17?,19-,20-,21?,22+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	750	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461886 (4-Chlorophenethyl 3-deoxy-3-[4-(3,4,5-trifluorophe...) Show SMILES OCC1O[C@H](SCCc2ccc(Cl)cc2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C22H21ClF3N3O4S/c23-13-3-1-11(2-4-13)5-6-34-22-21(32)19(20(31)17(10-30)33-22)29-9-16(27-28-29)12-7-14(24)18(26)15(25)8-12/h1-4,7-9,17,19-22,30-32H,5-6,10H2/t17?,19-,20-,21?,22+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	760	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461887 (2-Chlorobenzyl 3-deoxy-1-thio-3-[4-(3,4,5-trifluor...) Show SMILES OCC1O[C@H](SCc2ccccc2Cl)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C21H19ClF3N3O4S/c22-12-4-2-1-3-10(12)9-33-21-20(31)18(19(30)16(8-29)32-21)28-7-15(26-27-28)11-5-13(23)17(25)14(24)6-11/h1-7,16,18-21,29-31H,8-9H2/t16?,18-,19-,20?,21+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	770	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461888 (3,4-Dichlorobenzyl 3-deoxy-1-thio-3-[4-(3,4,5-trif...) Show SMILES OCC1O[C@H](SCc2ccc(Cl)c(Cl)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C21H18Cl2F3N3O4S/c22-11-2-1-9(3-12(11)23)8-34-21-20(32)18(19(31)16(7-30)33-21)29-6-15(27-28-29)10-4-13(24)17(26)14(25)5-10/h1-6,16,18-21,30-32H,7-8H2/t16?,18-,19-,20?,21+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	790	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461889 (3-Chlorophenethyl 3-deoxy-3-[4-(3,4,5-trifluorophe...) Show SMILES OCC1O[C@H](SCCc2cccc(Cl)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C22H21ClF3N3O4S/c23-13-3-1-2-11(6-13)4-5-34-22-21(32)19(20(31)17(10-30)33-22)29-9-16(27-28-29)12-7-14(24)18(26)15(25)8-12/h1-3,6-9,17,19-22,30-32H,4-5,10H2/t17?,19-,20-,21?,22+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	820	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461890 (4-Chlorobenzyl 3-deoxy-1-thio-3-[4-(3,4,5-trifluor...) Show SMILES OCC1O[C@H](SCc2ccc(Cl)cc2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C21H19ClF3N3O4S/c22-12-3-1-10(2-4-12)9-33-21-20(31)18(19(30)16(8-29)32-21)28-7-15(26-27-28)11-5-13(23)17(25)14(24)6-11/h1-7,16,18-21,29-31H,8-9H2/t16?,18-,19-,20?,21+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	950	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461891 (Propyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1H-1,2...) Show SMILES CCCS[C@H]1OC(CO)[C@H](O)[C@@H](C1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C17H20F3N3O4S/c1-2-3-28-17-16(26)14(15(25)12(7-24)27-17)23-6-11(21-22-23)8-4-9(18)13(20)10(19)5-8/h4-6,12,14-17,24-26H,2-3,7H2,1H3/t12?,14-,15-,16?,17+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	980	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461892 (2-Aminopyridin-4-yl 3-deoxy-3-[4-(3,4,5-trifluorop...) Show SMILES Nc1cc(S[C@H]2OC(CO)[C@H](O)[C@@H](C2O)n2cc(nn2)-c2cc(F)c(F)c(F)c2)ccn1 |r| Show InChI InChI=1S/C19H18F3N5O4S/c20-10-3-8(4-11(21)15(10)22)12-6-27(26-25-12)16-17(29)13(7-28)31-19(18(16)30)32-9-1-2-24-14(23)5-9/h1-6,13,16-19,28-30H,7H2,(H2,23,24)/t13?,16-,17-,18?,19+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	990	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461893 (5-dimethylamino-naphatlen-2-yl 3-deoxy-3-[4-(3,4,5...) Show SMILES CN(C)c1cccc2cc(S[C@H]3OC(CO)[C@H](O)[C@@H](C3O)n3cc(nn3)-c3cc(F)c(F)c(F)c3)ccc12 |r| Show InChI InChI=1S/C26H25F3N4O4S/c1-32(2)20-5-3-4-13-8-15(6-7-16(13)20)38-26-25(36)23(24(35)21(12-34)37-26)33-11-19(30-31-33)14-9-17(27)22(29)18(28)10-14/h3-11,21,23-26,34-36H,12H2,1-2H3/t21?,23-,24-,25?,26+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	1.06E+3	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461894 (Ethyl 3-deoxy-1-thio-3-[4-(3,4,5-trifloorophenyl)-...) Show SMILES CCS[C@H]1OC(CO)[C@H](O)[C@@H](C1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |r| Show InChI InChI=1S/C16H18F3N3O4S/c1-2-27-16-15(25)13(14(24)11(6-23)26-16)22-5-10(20-21-22)7-3-8(17)12(19)9(18)4-7/h3-5,11,13-16,23-25H,2,6H2,1H3/t11?,13-,14-,15?,16+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	1.10E+3	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461895 (5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...) Show SMILES OCC1O[C@H](C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1)S(=O)c1cncc(Br)c1 |r| Show InChI InChI=1S/C19H16BrF3N4O5S/c20-9-3-10(5-24-4-9)33(31)19-18(30)16(17(29)14(7-28)32-19)27-6-13(25-26-27)8-1-11(21)15(23)12(22)2-8/h1-6,14,16-19,28-30H,7H2/t14?,16-,17-,18?,19-,33?/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	28	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair
Galectin-3 (Homo sapiens (Human))	BDBM461897 (5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...) Show SMILES OCC1O[C@@H](C(O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1)S(=O)c1cncc(Br)c1 |r| Show InChI InChI=1S/C19H16BrF3N4O5S/c20-9-3-10(5-24-4-9)33(31)19-18(30)16(17(29)14(7-28)32-19)27-6-13(25-26-27)8-1-11(21)15(23)12(22)2-8/h1-6,14,16-19,28-30H,7H2/t14?,16-,17-,18?,19+,33?/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	130	n/a	n/a	n/a	n/a	n/a
Galecto Biotech AB US Patent					Assay Description The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...				US Patent US10774102 (2020) BindingDB Entry DOI: 10.7270/Q20P133G
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 260 total )  |  Next  |  Last  >>

Jump to: